Risk Management in the Pharmaceutical Product Development Process: White Paper Prepared by PhRMA Drug Product Technology Group

“The manufacture and use of a drug product, including its components, necessarily entail some degree of risk.”—International Conference for Harmonization (ICH) Q9. This paper examines the role of risk management in pharmaceutical product development in the context of patient safety and drug efficacy...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical innovation 2008-12, Vol.3 (4), p.227-248
Main Authors: Hulbert, Matthew H., Feely, Liam C., Inman, Eugene L., Johnson, Alton D., Kearney, Albert S., Michaels, James, Mitchell, Michael, Zour, Elena
Format: Article
Language:English
Subjects:
Biochemical Engineering
Biomedical and Life Sciences
Biomedicine
Biotechnology
Industrial and Production Engineering
Perspective
Pharmacology/Toxicology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:“The manufacture and use of a drug product, including its components, necessarily entail some degree of risk.”—International Conference for Harmonization (ICH) Q9. This paper examines the role of risk management in pharmaceutical product development in the context of patient safety and drug efficacy. Its objective is to contribute to building a common understanding of this quality risk management among the various functional groups involved in developing, testing, manufacturing, and approving of drug products within pharmaceutical companies and regulatory agencies. Selected aspects of drug substance and drug product development are used to demonstrate principles of risk management in action and presented as case studies.
ISSN:1872-5120
1939-8042
DOI:10.1007/s12247-008-9049-8